Collaborative Drug Discovery Partners With Eli Lilly to Integrate TuneLab AI Models Into CDD Vault

Collaborative Drug Discovery (CDD) announced a partnership with Eli Lilly to integrate TuneLab, a collaborative AI/ML drug discovery platform, into the CDD Vault software environment. The integration will allow biotech users to access select Lilly-developed predictive models trained on decades of proprietary research data directly within their existing workflows. The collaboration aims to improve decision-making in early drug discovery by embedding advanced machine learning tools such as ADMET and property prediction models into secure, cloud-based research data systems used across the biotech industry.